The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Leon; Im sorry but this will rise when the shorts decide its going to and that wont be until they orchestrate another big drop. The shorts are spending a lot of money keeping a glass ceiling in place at 288-290 and they wouldn't be spending that money unless they are confident they can get it down again to the 240 territory for a big buy back. Long term this will be sitting substantially over 500 because that's the point where the shorts started their latest campaign and they will want their profit too. all my opinion